AstraZeneca and Pillar Biosciences Partner to Accelerate Access to Liquid Biopsy Testing
Pillar Biosciences and AstraZeneca seek to expand access to NGS-based liquid biopsy tumor profiling to detect genetic cancer variants.
Tag: AstraZeneca
All
Latest
All
Latest
Tecan to Hold First Virtual Genomics Symposium
This one-day event will explore the latest advances in research, translational and clinical applications of genomics technologies.
All
Latest
FDA Approves First Treatment for Breast Cancer with a Certain Inherited Genetic Mutation
FDA has expanded the approved use of Lynparza to include the treatment of patients with certain types of breast cancer that have spread and whose tumors have a specific inherited genetic mutation, making it the first drug in its class approved to treat breast cancer.